Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
35.4M
-
Shares change
-
-382K
-
Total reported value, excl. options
-
$469M
-
Value change
-
-$87.9M
-
Put/Call ratio
-
1.57
-
Number of buys
-
66
-
Number of sells
-
-84
-
Price
-
$13.24
Significant Holders of ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) as of Q4 2024
203 filings reported holding ANAB - ANAPTYSBIO, INC - Common Stock, par value $0.001 per share as of Q4 2024.
ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (7.87M shares), FMR LLC (3.03M shares), BlackRock, Inc. (2.55M shares), VANGUARD GROUP INC (1.84M shares), Fairmount Funds Management LLC (1.82M shares), Frazier Life Sciences Management, L.P. (1.57M shares), TANG CAPITAL MANAGEMENT LLC (1.33M shares), Boxer Capital Management, LLC (1.3M shares), STATE STREET CORP (1.29M shares), and Camber Capital Management LP (1.25M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.